Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H29N3O3S |
| Molecular Weight | 403.538 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCC[C@]1(C)\C=C\S(=O)(=O)NC(=O)NC2=C3CCCC3=CC4=C2CCC4
InChI
InChIKey=HAMGPBKPACGWND-ZOXUKVPXSA-N
InChI=1S/C21H29N3O3S/c1-21(10-5-12-24(21)2)11-13-28(26,27)23-20(25)22-19-17-8-3-6-15(17)14-16-7-4-9-18(16)19/h11,13-14H,3-10,12H2,1-2H3,(H2,22,23,25)/b13-11+/t21-/m1/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
929522
Created by
admin on Wed Apr 02 15:08:07 GMT 2025 , Edited by admin on Wed Apr 02 15:08:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C203172
Created by
admin on Wed Apr 02 15:08:07 GMT 2025 , Edited by admin on Wed Apr 02 15:08:07 GMT 2025
|
PRIMARY | |||
|
154648184
Created by
admin on Wed Apr 02 15:08:07 GMT 2025 , Edited by admin on Wed Apr 02 15:08:07 GMT 2025
|
PRIMARY | |||
|
300000047834
Created by
admin on Wed Apr 02 15:08:07 GMT 2025 , Edited by admin on Wed Apr 02 15:08:07 GMT 2025
|
PRIMARY | |||
|
12822
Created by
admin on Wed Apr 02 15:08:07 GMT 2025 , Edited by admin on Wed Apr 02 15:08:07 GMT 2025
|
PRIMARY | |||
|
2455519-86-3
Created by
admin on Wed Apr 02 15:08:07 GMT 2025 , Edited by admin on Wed Apr 02 15:08:07 GMT 2025
|
PRIMARY | |||
|
P9ZQS28F8C
Created by
admin on Wed Apr 02 15:08:07 GMT 2025 , Edited by admin on Wed Apr 02 15:08:07 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
METABOLITE ACTIVE (PARENT)
METABOLITE ACTIVE (PARENT)
METABOLITE LESS ACTIVE (PARENT)
METABOLITE LESS ACTIVE (PARENT)
